Nonsurgical management of upper eyelid retraction in thyroid eye disease
Upper eyelid retraction (UER) is the most common sign of thyroid eye disease (TED) and may result in lagophthalmos and exposure keratopathy. Measures to address UER are varied and include conservative treatment, surgical intervention, and injections of botulinum toxin, hyaluronic acid (HA) filler, a...
Saved in:
Main Authors: | Stephanie Ming Young, Yoon-Duck Kim, Kyung In Woo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Taiwan Journal of Ophthalmology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/tjo.TJO-D-23-00043 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Graves’ upper eyelid retraction (GUER): A review
by: Akruti Desai, et al.
Published: (2025-02-01) -
A Study of Combined Onabotulinumtoxin A and Hyaluronic Acid Filler for the Treatment of Enlarged Facial Pores
by: Vasanop Vachiramon, et al.
Published: (2025-01-01) -
Benign eyelid lesions and its histopathological picture: A case-series
by: Shalini Kumari
Published: (2024-12-01) -
Type a botulinum toxin in the management of spontaneous salivary otorrhea: a case report
by: Teffran J. Chan, et al.
Published: (2020-08-01) -
Aquafilling Filler for Buttock Augmentation Cause Severe Long-Term Complications: A Case Report
by: Camilla Soendergaard Kristiansen, et al.